Cargando…

Pravastatin Use and the Five-year Incidence of Cancer in Coronary Heart Disease Patients: from the Prevention of Coronary Sclerosis Study

BACKGROUND: Although the short-term safety of statins is well established, their potential carcinogenicity in the long term is still being debated. The aim of this study was to investigate the association between statin-therapy and the incidence of cancer in coronary heart disease patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Shinichi, Ajiki, Wakiko, Kobayashi, Tohru, Awata, Nobuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Epidemiological Association 2006
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683703/ https://www.ncbi.nlm.nih.gov/pubmed/16951539 http://dx.doi.org/10.2188/jea.16.201

Ejemplares similares

Evaluation of Coronary Artery Calcification by Multi-detector Row Computed Tomography for the Detection of Coronary Artery Stenosis in Japanese Patients
por: Kitamura, Akihiko, et al.
Publicado: (2005)

Incidence of Childhood Cancer in Osaka, Japan, 1971–1988: Reclassification of Registered Cases by Birch's Scheme Using Information on Clinical Diagnosis, Histology and Primary Site
por: Ajiki, Wakiko, et al.
Publicado: (1994)

Trends of Lung Cancer Incidence by Histologic Type: A Population‐based Study in Osaka, Japan
por: Sobue, Tomotaka, et al.
Publicado: (1999)

Pravastatin for prevention of HELLP syndrome: A case report
por: Otten, Lucia Anna, et al.
Publicado: (2017)

Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning
por: Dogan, Meeshanthini V., et al.
Publicado: (2018)

Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study
por: White, Harvey D., et al.
Publicado: (2013)

Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin
por: Kawahara, Takuya, et al.
Publicado: (2020)

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes
por: Kiviniemi, Tuomas O., et al.
Publicado: (2012)

Pravastatin reduces radiation-induced damage in normal tissues
por: Doi, Hiroshi, et al.
Publicado: (2017)

Suicide Risk among Cancer Patients: Experience at One Medical Center in Japan, 1978–1994
por: Tanaka, Hideo, et al.
Publicado: (1999)

Second Primary Cancers Following Non‐Hodgkin's Lymphoma in Japan: Increased Risk of Hepatocellular Carcinoma
por: Tanaka, Hideo, et al.
Publicado: (1997)

Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Freeman, Dilys J, et al.
Publicado: (2011)

Survival Rates of Childhood Cancer Patients in Osaka, Japan, 1975–1984
por: Ajiki, Wakiko, et al.
Publicado: (1995)

Improvement of Survival Over Time for Colon Cancer Patients by Anatomical Sub‐sites
por: Kawazuma, Yoshikazu, et al.
Publicado: (1999)

Coronary Sclerosis
Publicado: (1925)

The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years
por: Du, Jinling, et al.
Publicado: (2016)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Cigarette Smoking, Incident Coronary Heart Disease, and Coronary Artery Calcification in Black Adults: The Jackson Heart Study
por: Oshunbade, Adebamike A., et al.
Publicado: (2021)

Effects of Pravastatin on Type 1 Diabetic Rat Heart with or without Blood Glycemic Control
por: Min, Jeong Jin, et al.
Publicado: (2018)

Coronary Arterio-Sclerosis
Publicado: (1926)

Effect of Pravastatin on Echocardiographic Circulation Parameters in Dogs
por: ARITA, Shinji, et al.
Publicado: (2013)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
por: Salna, Michael P., et al.
Publicado: (2017)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
por: Csomó, Krisztián, et al.
Publicado: (2022)

Statins for the Primary Prevention of Coronary Heart Disease
por: Li, Min, et al.
Publicado: (2019)

Revisiting secondary prevention in coronary heart disease
por: Sigamani, Alben, et al.
Publicado: (2022)

Accumulation of Non-Traditional Risk Factors for Coronary Heart Disease Is Associated with Incident Coronary Heart Disease Hospitalization and Death
por: Wallace, Lindsay M. K., et al.
Publicado: (2014)

Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries)
por: Viladés-Medel, David, et al.
Publicado: (2022)

Neuroprotective effects of pravastatin in cerebral venous infarction in a rat model
por: Sato, Fumiya, et al.
Publicado: (2023)

Five-years’ prognostic analysis for coronary artery ectasia patients with coronary atherosclerosis: A retrospective cohort study
por: Liu, Ruifeng, et al.
Publicado: (2022)

Coronary heart disease incidence and competing risks: an important issue
por: Puddu, Paolo Emilio, et al.
Publicado: (2017)

Mode of transport, genetic susceptibility, and incidence of coronary heart disease
por: Jiesisibieke, Zhu Liduzi, et al.
Publicado: (2023)

Risk Factor Control Five Years after Coronary Bypass Grafting
por: Skinner, J S, et al.
Publicado: (1996)

Effect of pravastatin on the survival of patients with advanced gastric cancer
por: Bujanda, Luis, et al.
Publicado: (2015)

Pravastatin in preeclampsia: A meta-analysis and systematic review
por: Mészáros, Balázs, et al.
Publicado: (2023)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Mediterranean diet and prevention of coronary heart disease in the elderly
por: Dontas, Anastasios S, et al.
Publicado: (2007)

The current status of primary prevention in coronary heart disease
por: Pater, Cornel
Publicado: (2001)

Prevention of Coronary Heart Disease: Putting Theory into Practice
por: Lewis, Barry, et al.
Publicado: (1991)

Effects of pravastatin on the pharmacokinetic parameters of nimodipine after oral and intravenous administration in rats: Possible role of CYP3A4 inhibition by pravastatin
por: Lee, Chong-Ki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sl3rck424b6fk5jp2r9n5rfms9